Received May 30, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
got inadequate dose; This non-serious case was reported by a consumer via sales rep and described the occurrence of underdose in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced underdose (Verbatim: got inadequate dose). The outcome of the underdose was not applicable. Additional Information: GSK Receipt Date: 27-MAY-2025 Reporter stated that essentially someone got an inadequate dose and cannot figure out what patient it was. Also asked are there recs on re-vaccinating with not knowing what patient it was. They narrowed it down to about 10 patients, no more data was provided. Patient received inadequate dose, which led to underdose.